Intranasal fentanyl spray benefits compared with oral agents for breakthrough cancer pain


Patients with breakthrough cancer pain (BTCP) may want to consider intranasal fentanyl spray over oral agents to treat their breakthrough pain because of improved onset of analgesia and avoidance of nausea and vomiting, according to a report published online for The Annals of Pharmacotherapy.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.